Literature DB >> 3525056

Comparison of metabolic effects of white beans processed into two different physical forms.

A Golay, A M Coulston, C B Hollenbeck, L L Kaiser, P Würsch, G M Reaven.   

Abstract

In the present study eight control subjects and eight patients with non-insulin-dependent diabetes mellitus (NIDDM) consumed single portions of processed beans equivalent to 50 g of carbohydrate. The beans were processed by different methods into two physical forms; one maintained the integrity of the bean cells (undamaged bean cells, UC) and the other ruptured the bean cells (damaged bean cells, DC). Incremental glucose response areas after ingestion of either UC or DC were not significantly different in control subjects, while incremental insulin response areas (49 +/- 7 vs. 26 +/- 4 microU X ml-1 X h-1, P less than .05) were significantly lower after eating UC-processed beans. In patients with NIDDM both incremental glucose (150 +/- 14 vs. 73 +/- 25 mg X dl-1 X h-1, P less than .001) and insulin (67 +/- 16 vs. 46 +/- 11 microU X ml-1 X h-1, P less than .05) response areas were significantly lower after UC administration. To test the effectiveness of the UC-processed bean when incorporated into mixed meals, nine patients with NIDDM consumed mixed meals containing either DC or UC on two separate mornings. The test meals represented a typical Mexican American use of pureed beans wrapped in a flour tortilla topped with melted cheese. Incremental glucose responses were significantly lower after the UC meal (171 +/- 42 mg X dl-1 X h-1, P less than .05) when compared with the DC meal (212 +/- 34 mg X dl-1 X h-1). Incremental insulin areas were also lower after the UC (91 +/- 19 microU X ml-1 X h-1) when compared with the DC meal (120 +/- 22 microU X ml-1 X h-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525056     DOI: 10.2337/diacare.9.3.260

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Glucose-stimulated insulin secretion in gastric bypass patients with hypoglycemic syndrome: no evidence for inappropriate pancreatic beta-cell function.

Authors:  Sun H Kim; Fahim Abbasi; Cindy Lamendola; Gerald M Reaven; Tracey McLaughlin
Journal:  Obes Surg       Date:  2010-08       Impact factor: 4.129

2.  Black Bean Pasta Meals with Varying Protein Concentrations Reduce Postprandial Glycemia and Insulinemia Similarly Compared to White Bread Control in Adults.

Authors:  Donna M Winham; Sharon V Thompson; Michelle M Heer; Elizabeth D Davitt; Sharon D Hooper; Karen A Cichy; Simon T Knoblauch
Journal:  Foods       Date:  2022-06-03

3.  Lipid-lowering effect of maize-based traditional Mexican food on a metabolic syndrome model in rats.

Authors:  Juan Manuel Muñoz Cano; Andrea Carrillo Aguilar; Juan Córdova Hernández
Journal:  Lipids Health Dis       Date:  2013-03-15       Impact factor: 3.876

Review 4.  Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism.

Authors:  Myriam M-L Grundy; Cathrina H Edwards; Alan R Mackie; Michael J Gidley; Peter J Butterworth; Peter R Ellis
Journal:  Br J Nutr       Date:  2016-07-07       Impact factor: 3.718

5.  Incorporation of a novel leguminous ingredient into savoury biscuits reduces their starch digestibility: Implications for lowering the Glycaemic Index of cereal products.

Authors:  Gael Y F Delamare; Peter J Butterworth; Peter R Ellis; Sandra Hill; Frederick J Warren; Cathrina H Edwards
Journal:  Food Chem X       Date:  2020-02-07

6.  Manipulation of starch bioaccessibility in wheat endosperm to regulate starch digestion, postprandial glycemia, insulinemia, and gut hormone responses: a randomized controlled trial in healthy ileostomy participants.

Authors:  Cathrina H Edwards; Myriam Ml Grundy; Terri Grassby; Dafni Vasilopoulou; Gary S Frost; Peter J Butterworth; Sarah Ee Berry; Jeremy Sanderson; Peter R Ellis
Journal:  Am J Clin Nutr       Date:  2015-09-02       Impact factor: 7.045

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.